Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page
- Check2 days agoChange DetectedThe service alert has been updated to reflect a planned maintenance period starting on July 25th, with services expected to be unavailable for over 24 hours, compared to the previous alert which indicated maintenance starting on July 26th for 12 hours.SummaryDifference1%
- Check9 days agoChange DetectedA service alert has been added indicating planned maintenance on July 26th, during which most services will be unavailable for over 12 hours starting at 6 AM EDT.SummaryDifference3%
- Check16 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference3%
- Check24 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference1%
- Check45 days agoChange DetectedDifference1%
Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.